GoldenGolden
BigHat Biosciences

BigHat Biosciences

BigHat Biosciences is a company with a mission to enhance human health by making it easier to design advanced antibody therapeutics.

BigHat Biosciences is a company with a mission to enhance human health by making it easier to design advanced antibody therapeutics. It integrates a wet lab for high-speed characterization with ML technologies to aid the search for better antibodies.

Timeline

February 10, 2021
BigHat Biosciences Raises $19M Series A For Antibody.

BigHat Biosciences raises $19 million in an oversubscribed Series A funding round to integrate a wet lab with machine learning technologies.

Andreessen Horowitz led the round with participation from prior investors 8VC, 1 AME Cloud Ventures and Innovation Endeavors.

February 2021
BigHat Biosciences raises a $19,000,000 series A round from 8VC, AME Cloud Ventures, Andreessen Horowitz and Innovation Endeavors.
2019
BigHat Biosciences raises a $5,300,000 seed round from 8VC.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
BigHat Biosciences Series A round, February 2021
19,000,000
February 2021
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Amirah Al Idrus
February 10, 2021
FierceBiotech
BigHat Biosciences raised $19 million to further develop its AI-based antibody design platform, make it scalable and advance a suite of programs toward the clinic. it will also use the funds to build the teams that will make this possible, with plans to hire protein engineers, artificial intelligence and machine learning engineers, and computational biologists.
Christine Hall
February 10, 2021
Crunchbase News
Most popular drugs prescribed today are biologics, and more than 200 biotherapeutics are used today, generating more than $100 billion in annual revenue for drug companies

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.